liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia
Department of Medicine, University of Sydney, Nepean Hospital, Penrith, NSW, Australia.
Department of Medicine, University of Sydney, Nepean Hospital, Penrith, NSW, Australia, Department of Medicine, University of Sydney, Nepean Hospital, PO Box 63, Penrith, NSW 2751, Australia.
Division of Gastroenterology, Ctr. Hosp. Universitaire Vaudois, Lausanne, Switzerland.
Department of Gastroenterology, Meath Hospital, Trinity College, Dublin, Ireland.
Show others and affiliations
2003 (English)In: Alimentary Pharmacology and Therapeutics, ISSN 0269-2813, E-ISSN 1365-2036, Vol. 17, no 7, 935-943 p.Article in journal (Refereed) Published
Abstract [en]

Aim: To determine whether pre-treatment antibody response to Helicobacter pylori virulence factors predicts eradication success and symptom relief 12 months after triple therapy in non-ulcer dyspepsia. Methods: H. pylori-positive patients with non-ulcer dyspepsia received 1-week omeprazole-based triple therapy, or omeprazole plus placebos. Symptoms were assessed using a validated Likert scale. Gastric biopsies taken before and 12 months after treatment were used for histological examination. Pre-treatment blood samples were used for the detection of anti-H. pylori immunoglobulin G (IgG) antibodies, and specific IgG antibodies to 19.5-, 26.5-, 30-, 35-, 89- (VacA) and 116-KDa (CagA) antigens of H. pylori. Results: IgG antibodies to the six antigens were detected in 62%, 96%, 88%, 47%, 54% and 78% of patients, respectively. The presence of antibody to 19.5-, 26.5- or 30-kDa antigen was associated with an increased anti-H. pylori IgG absorbance index. IgG absorbance indices were greater in those with H. pylori eradication (vs. persistent infection). The prevalence of antibodies to the six antigens was not significantly different between those with symptom relief vs. those without. The 19.5kDa antigen (P = 0.018) and VacA (P = 0.001) were independent risk factors for body gastritis. Conclusions: An increased pre-treatment anti-H. pylori IgG absorbance index may be a useful predictor of the success of eradication therapy. Although the 19.5-kDa antigen and VacA were associated with body gastritis, none of the six antigens tested predicted symptom relief after triple therapy.

Place, publisher, year, edition, pages
2003. Vol. 17, no 7, 935-943 p.
National Category
Natural Sciences
URN: urn:nbn:se:liu:diva-46691DOI: 10.1046/j.1365-2036.2003.01525.xOAI: diva2:267587
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2012-01-07

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Department of Biomedicine and SurgeryFaculty of Health Sciences
In the same journal
Alimentary Pharmacology and Therapeutics
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 19 hits
ReferencesLink to record
Permanent link

Direct link